Literature DB >> 14678752

Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.

E J Wolvetang1, O M Bradfield, T Hatzistavrou, P J Crack, J Busciglio, I Kola, P J Hertzog.   

Abstract

Down syndrome (trisomy 21) neurons display an increased rate of apoptosis in vitro. The genes on chromosome 21 that mediate this increased cell death remain to be elucidated. Here we show that the chromosome 21 transcription factor Ets2, a gene that is overexpressed in Down syndrome, is expressed in neurons, and that moderate overexpression of Ets2 leads to increased apoptosis of primary neuronal cultures from Ets2 tg mice that involves activation of caspase-3. Our data therefore suggest that overexpression of ETS2 may contribute to the increased rate of apoptosis of neurons in Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678752     DOI: 10.1016/s0969-9961(03)00107-4

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  12 in total

1.  Gene expression variation increase in trisomy 21 tissues.

Authors:  Ching Yu Chou; Li Yu Liu; Chien Yu Chen; Cheng Hsien Tsai; Hsiao Lin Hwa; Li Yun Chang; Yi Shing Lin; Fon Jou Hsieh
Journal:  Mamm Genome       Date:  2008-07-02       Impact factor: 2.957

2.  The Etv1/Er81 transcription factor orchestrates activity-dependent gene regulation in the terminal maturation program of cerebellar granule cells.

Authors:  Haruka Abe; Makoto Okazawa; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

3.  Role for Ets-2(Thr-72) transcription factor in stage-specific thymocyte development and survival.

Authors:  Ian B Fisher; Mike Ostrowski; Natarajan Muthusamy
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

4.  Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome.

Authors:  Annan Yang; Roger H Reeves
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

Review 5.  Neurogenetic disorders across the lifespan: from aberrant development to degeneration.

Authors:  Richard A Hickman; Sarah A O'Shea; Mark F Mehler; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

6.  Preparation, crystallization and preliminary X-ray diffraction analysis of the DNA-binding domain of the Ets transcription factor in complex with target DNA.

Authors:  Yoshiaki Suwa; Teruya Nakamura; Sachiko Toma; Shinji Ikemizu; Hirofumi Kai; Yuriko Yamagata
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-02-23

Review 7.  Lineage divergence of activity-driven transcription and evolution of cognitive ability.

Authors:  Giles E Hardingham; Priit Pruunsild; Michael E Greenberg; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2017-11-23       Impact factor: 34.870

8.  The use of mouse models for understanding the biology of down syndrome and aging.

Authors:  Guido N Vacano; Nathan Duval; David Patterson
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-23

9.  Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.

Authors:  Arpita Chatterjee; Samikshan Dutta; Sanjit Mukherjee; Nupur Mukherjee; Avirup Dutta; Ashis Mukherjee; Swagata Sinha; Chinmay Kumar Panda; Keya Chaudhuri; Ananda L Roy; Kanchan Mukhopadhyay
Journal:  BMC Med Genet       Date:  2013-01-23       Impact factor: 2.103

10.  ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.

Authors:  G De la Houssaye; V Vieira; C Masson; F Beermann; J L Dufier; M Menasche; M Abitbol
Journal:  Mol Vis       Date:  2008-10-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.